Online citations, reference lists, and bibliographies.
← Back to Search

Nucleolin Targeting AS1411 Modified Protein Nanoparticle For Antitumor Drugs Delivery.

J. Wu, Chenchen Song, Chenxiao Jiang, Xin Shen, Q. Qiao, Y. Hu
Published 2013 · Chemistry, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Over recent years, cell surface nucleolin as an anticancer target has attracted many researchers' attentions. To improve the antitumor efficacy, we developed a nucleolin targeted protein nanoparticle (NTPN) delivery system in which human serum albumin (HSA) was used as drug carrier and a DNA aptamer named AS1411, which had high affinity to nucleolin, was used as a bullet. The HSA nanoparticles (NPs-PTX) were fabricated by a novel self-assembly method and then modified with AS1411 (Apt-NPs-PTX). The resulted Apt-NPs-PTX were spherical. Compared with NPs-PTX, the uptake of Apt-NPs-PTX displayed a significant increase in MCF-7 cells while there was a decrease in nontumor cell lines such as MCF-10A and 3T3 cells. In a cytotoxic study, Apt-NPs-PTX displayed an enhanced cytotoxicity in MCF-7 tumor cells while there was almost no cytotoxicity in MCF-10A cells. Endostatin, a nucleolin inhibitor, could significantly decrease the internalization of Apt-NPs-PTX, suggesting nucleolin mediates the transmembrane process of Apt-NPs-PTX. Therefore, the AS1411 modified NTPN delivery system might be a promising targeted drug delivery system.
This paper references
10.1021/bm201401s
Molecular switch for the assembly of lipophilic drug incorporated plasma protein nanoparticles and in vivo image.
Guangming Gong (2012)
10.1615/CRITREVTHERDRUGCARRIERSYST.V26.I4.10
Paclitaxel in cancer treatment: perspectives and prospects of its delivery challenges.
S. Singh (2009)
10.1016/J.EJPS.2005.08.002
In vivo tumor targeting of tumor necrosis factor-alpha-loaded stealth nanoparticles: effect of MePEG molecular weight and particle size.
Chao Fang (2006)
10.1073/PNAS.77.3.1561
Taxol stabilizes microtubules in mouse fibroblast cells.
P. Schiff (1980)
10.1016/j.coph.2010.06.009
Development of aptamer therapeutics.
D. Bunka (2010)
10.1021/BI0119520
Antiproliferative activity of G-quartet-forming oligonucleotides with backbone and sugar modifications.
Virna Dapić (2002)
10.1182/BLOOD-2007-01-064428
Nucleolin is a receptor that mediates antiangiogenic and antitumor activity of endostatin.
Hubing Shi (2007)
The amino terminus of mammalian nucleolin specifically recognizes SV40 T-antigen type nuclear localization sequences.
Z. Xue (1993)
10.1007/s11095-010-0069-y
Influence of Preparation Methods on Solid State Supersaturation of Amorphous Solid Dispersions: A Case Study with Itraconazole and Eudragit E100
Sandrien Janssens (2010)
10.1007/s10856-010-4213-3
Evaluation of two polymeric blends (EVA/PLA and EVA/PEG) as coating film materials for paclitaxel-eluting stent application
X. Liu (2011)
10.1158/1535-7163.MCT-06-0172
Discovery and development of anticancer aptamers
C. Ireson (2006)
10.1016/j.yexmp.2009.01.004
Discovery and development of the G-rich oligonucleotide AS1411 as a novel treatment for cancer.
P. Bates (2009)
10.1016/j.ijpharm.2012.04.032
Enhanced antitumor efficacy of cisplatin by tirapazamine-transferrin conjugate.
L. Wu (2012)
10.1016/S0168-3659(97)00149-1
Relating the phagocytosis of microparticles by alveolar macrophages to surface chemistry: the effect of 1,2-dipalmitoylphosphatidylcholine.
C. Évora (1998)
10.1002/smll.200901158
Effect of surface properties on nanoparticle-cell interactions.
Ayush Verma (2010)
10.1007/s11095-007-9348-7
Sheddable Coatings for Long-Circulating Nanoparticles
B. Romberg (2007)
10.1074/jbc.274.37.26369
Antiproliferative Activity of G-rich Oligonucleotides Correlates with Protein Binding*
P. Bates (1999)
10.1016/j.biomaterials.2011.07.004
Aptamer-functionalized PEG-PLGA nanoparticles for enhanced anti-glioma drug delivery.
Jianwei Guo (2011)
10.1096/fasebj.13.14.1911
Molecular dissection of nucleolin's role in growth and cell proliferation: new insights
M. Srivastava (1999)
10.1016/j.bbamem.2010.02.004
Delivering cargoes into cancer cells using DNA aptamers targeting internalized surface portals.
E. Orava (2010)
10.1006/EXCR.2000.5071
The cell-surface-expressed nucleolin is associated with the actin cytoskeleton.
A. Hovanessian (2000)
10.1002/1097-0142(20011115)92:10<2592::AID-CNCR1612>3.0.CO;2-4
Intraarterial chemotherapy with polyoxyethylated castor oil free paclitaxel, incorporated in albumin nanoparticles (ABI‐007)
B. Damascelli (2001)
10.1074/jbc.M104446200
Inhibition of DNA Replication and Induction of S Phase Cell Cycle Arrest by G-rich Oligonucleotides*
X. Xu (2001)
10.1016/j.jconrel.2011.07.031
Albumin-based nanoparticles as potential controlled release drug delivery systems.
Ahmed O Elzoghby (2012)
10.1016/j.addr.2007.08.044
Protein nanoparticles as drug carriers in clinical medicine.
M. Hawkins (2008)
10.1038/nnano.2012.45
Normalization of tumour blood vessels improves the delivery of nanomedicines in a size-dependent manner
Vikash P. Chauhan (2012)
10.1200/JCO.1995.13.1.180
Nonlinear pharmacokinetics and metabolism of paclitaxel and its pharmacokinetic/pharmacodynamic relationships in humans.
L. Gianni (1995)
Phase I trial of cremophor EL with bolus doxorubicin.
MichaelJ. Millward (1998)
10.1016/0076-6879(86)30013-2
Calculation of protein conformation from circular dichroism.
J. Yang (1986)
10.1093/JNCI/82.15.1247
Taxol: a novel investigational antimicrotubule agent.
E. Rowinsky (1990)
10.1002/anie.200901452
Reversible cell-specific drug delivery with aptamer-functionalized liposomes.
Z. Cao (2009)
10.2217/fon.10.67
Aptamer applications for targeted cancer therapy.
A. Barbas (2010)



This paper is referenced by
10.1016/j.nantod.2020.100987
Plasmonic modulation of gold nanotheranostics for targeted NIR-II photothermal-augmented immunotherapy
Yi-fan Zhang (2020)
10.3390/s150716281
Nucleic Acid Aptamers: An Emerging Tool for Biotechnology and Biomedical Sensing
T. Ku (2015)
10.18632/ONCOTARGET.4207
AS1411-conjugated gold nanospheres and their potential for breast cancer therapy
M. Malik (2015)
10.1016/j.talanta.2018.10.094
Folic acid-modified fluorescent dye-protein nanoparticles for the targeted tumor cell imaging.
Lijun Xu (2019)
10.1126/sciadv.aaz9240
Targeting pulmonary tumor microenvironment with CXCR4-inhibiting nanocomplex to enhance anti–PD-L1 immunotherapy
Zhaoting Li (2020)
10.1016/B978-0-323-46143-6.00024-5
Drug delivery mediated by confined nanosystems: structure-activity relations and factors responsible for the efficacy of formulations
L. Y. Zakharova (2017)
10.1016/j.ajps.2018.07.005
Delivery of docetaxel using pH-sensitive liposomes based on D-α-tocopheryl poly(2-ethyl-2-oxazoline) succinate: Comparison with PEGylated liposomes
Shu Han (2019)
10.1080/17425247.2020.1813713
Self-assembled non-covalent protein-drug nanoparticles: an emerging delivery platform for anti-cancer drugs
Islam A Hassanin (2020)
10.1080/1061186X.2020.1830407
Polypod-like structured guanine-rich oligonucleotide aptamer as a selective and cytotoxic nanostructured DNA to cancer cells.
Kohta Mohri (2020)
10.1016/j.talanta.2016.06.067
Organic additives stabilize RNA aptamer binding of malachite green.
Y. Zhou (2016)
10.1016/j.colsurfb.2020.110985
Fabrication of aptamer modified TiO2 nanofibers for specific capture of circulating tumor cells.
H. Liu (2020)
10.2217/nnm-2018-0180
AS1411 aptamer-targeted gold nanoclusters effect on the enhancement of radiation therapy efficacy in breast tumor-bearing mice.
Fatemeh Ghahremani (2018)
10.1146/annurev-pharmtox-010716-104558
Aptamers as Therapeutics.
Shahid M. Nimjee (2017)
Targeting Transcription Factor NF-kappa B by Dual Functional Oligodeoxynucleotide Complex for Inhibition of Neuroinflammation
J. Hu (2015)
10.5772/63265
Aptamer-Mediated Selective Protein Affinity to Improve Scaffold Biocompatibility
L. Parisi (2016)
10.2147/IJN.S202561
Novel nanosized AS1411–chitosan–BODIPY conjugate for molecular fluorescent imaging
Setareh Taki (2019)
10.1016/j.critrevonc.2018.03.008
Meeting the needs of breast cancer: A nucleolin's perspective.
Ana C. Gregório (2018)
10.1371/journal.pone.0233466
Delivery of thymoquinone to cancer cells with as1411-conjugated nanodroplets
E. M. Murphy (2020)
10.1016/j.msec.2017.03.024
Combinatorial delivery of superparamagnetic iron oxide nanoparticles (γFe2O3) and doxorubicin using folate conjugated redox sensitive multiblock polymeric nanocarriers for enhancing the chemotherapeutic efficacy in cancer cells.
Chetan Nehate (2017)
10.2174/1381612821666150302115411
Recent advances on the development of pharmacotherapeutic agents on the basis of human serum albumin.
F. Liu (2015)
10.2147/IJN.S168660
T1–T2 molecular magnetic resonance imaging of renal carcinoma cells based on nano-contrast agents
J. Li (2018)
10.1016/j.nano.2019.102053
Noncovalent tethering of nucleic acid aptamer on DNA nanostructure for targeted photo/chemo/gene therapies.
G. Shim (2019)
10.1016/j.drudis.2019.06.018
Nucleolin-based targeting strategies for cancer therapy: from targeted drug delivery to cytotoxic ligands.
S. Romano (2019)
10.1039/C4PY01698J
Multifunctional ATRP based pH responsive polymeric nanoparticles for improved doxorubicin chemotherapy in breast cancer by proton sponge effect/endo-lysosomal escape
Shantanu V. Lale (2015)
10.1016/j.xphs.2015.12.007
One-Step Self-Assembling Method to Prepare Dual-Functional Transferrin Nanoparticles for Antitumor Drug Delivery.
Kaikai Wang (2016)
10.5772/INTECHOPEN.75603
Applications of Aptamers in Cancer Therapy
Ajda Coker-Gurkan (2018)
10.1002/cbf.3505
The influencing factors and functions of DNA G‐quadruplexes
Wen-Fang Yuan (2020)
10.1039/C9BM00403C
Dual-selective photodynamic therapy with a mitochondria-targeted photosensitizer and fiber optic cannula for malignant brain tumors.
Ji Hee Kang (2019)
10.1021/acsami.6b14885
Relighting Photosensitizers by Synergistic Integration of Albumin and Perfluorocarbon for Enhanced Photodynamic Therapy.
H. Ren (2017)
10.1016/j.ijpharm.2019.118561
Investigation of ultrafine gold nanoparticles (AuNPs) based nanoformulation as single conjugates target delivery for improved methotrexate chemotherapy in breast cancer.
Farhat Naz (2019)
10.1039/C2DT30853C
Synthesis, characterization and biocompatibility evaluation of iron oxide incorporated magnetic mesoporous silica.
Sakthivel Gandhi (2012)
10.1039/C6TB03365B
Nucleolin-targeted selenium nanocomposites with enhanced theranostic efficacy to antagonize glioblastoma.
Lizhen He (2017)
See more
Semantic Scholar Logo Some data provided by SemanticScholar